How can Intelligent Commercialization™ help pharma teams launch with success?

Insights from Inizio experts: Chris Savage, Jo Ann Saitta, Gerard Mortimer, and David Woods.

Why HCP engagement is critical to pharma launch success

A successful launch hinges on many factors, and one of the most important is HCP engagement. So how can you make sure that every interaction drives the right behavior from day one?

Getting your new asset to appropriate patients who need it can only happen if your campaign delivers the right messages to the right HCPs at the right time, via the right channels.

The 5 beliefs that influence HCP behavior

For those messages to influence HCP beliefs, and ultimately drive desired behaviors, they must convey five core beliefs:

1. Belief in the disease state. 
2. Belief in the science behind the therapy and its delivery system.
3. Belief or knowledge that the company is committed to a specific therapeutic area or disease state.
4. Belief that the therapy is the best option for patients.
5. Belief that patients will be able to access the product if an HCP prescribes it.

While not every organization will need to address all five of these beliefs, it’s critical to not only understand where HCPs are on the belief spectrum but also to understand what resources are best positioned to address those beliefs efficiently. “The optimal way of driving those beliefs is by understanding your audience and their needs, and tailoring your engagement strategy both at the HCP universe and individual level,” says Chris Savage, Managing Director at Propensity4, an Inizio Engage company. “At Inizio, we deliver these tailored engagement strategies through our 4D model.”

The 4D model for successful pharma commercialization

The 4D model acts as a model for the creation, execution, and continual improvement of Inizio’s engagement efforts across our commercial, medical, and patient services teams.

1. Diagnose where the product sits in the brand lifecycle and discover what key data and insights are telling you about positioning, patients, and their treatment journeys.
2. Design a solution that includes a holistic view of current and future engagement strategies.
3. Deploy a high-performance, channel-specific strategy that includes the right HCPs receiving the right content through the right channels at the right time.
4. Drive success through continued monitoring and evolution of the delivery model to maximize impact.

To deliver this model and achieve launch success for our clients, we not only leverage our expertise across Inizio, but we also bring together many of our proprietary data-driven tools.

Diagnose the market and brand opportunity with Predictev™

Predictev™ is our AI-powered predictive intelligence tool built on over 35m hours of exclusive HCP and patient behavioral data, gathered by Inizio over several years. That data is overlaid with a ChatGPT-style interface to allow teams to ask plain-language questions. These quickly generate insights to shape strategy and field engagement – all before you commit to budget.

This allows cross-functional pharma teams to gain early indicators on emerging trends, risks, and opportunities, and to quantify impact and risk under different market conditions.

Design the engagement strategy with DataGateway

If Predictev™ gives insight into the market and its potential, DataGateway helps you take action. It’s a framework and methodology that accelerates launch decisions by taking a company’s fragmented data and turning it into scalable, patient-level intelligence.

Building an actionable data foundation

“We start by developing a client’s data strategy to align with their business or launch challenge. This includes making sure we have the right data to build the foundation using proprietary Inizio behavioral data, client data, and third-party real-world data, such as claims, laboratory, or genomic data” explains Jo Ann Saitta, Global Head of Data Strategy, Analytics, and AI at Inizio Ignite.

“From there it’s about bringing disparate data together and structuring it into clean, ready-to-use datasets that provide a granular understanding of patient journeys. That data has to be transformed by clinical business rules for it to be used by commercial teams to make launch decisions. The next stage is to visualize it within launch readiness decision intelligence platforms. All datasets are then ready for predictive modeling, advanced analytics, and AI-driven use cases.”

Using patient intelligence before and during launch

This patient-level intelligence can be used at all stages of the launch process. For example, before launch you can move away from targeting HCPs based on historical or analogue sales to more precise, AI-driven micro-segmentation of treaters along the expected patient journey. While at launch, instead of static dashboards or disjointed touchpoints, a patient intelligence platform enables you to see what’s happening, enabling teams to rapidly pivot tactics or investments and optimize accordingly.

DataGateway in action: An oncology launch example

“What does that look like in practice? One of our large oncology clients was unclear which patient segments, accounts, and pathways drove uptake,” Jo Ann says. “Fragmented data was causing insight delays of up to four months, which in turn was impacting patient flow and performance. We applied DataGateway to create a scalable, claims-derived intelligence layer to support better targeting and tracking.

“As a result, they were able to unlock visibility to almost $50m in hidden quarterly revenue, save $1.5m a year through efficiency gains, and accelerate insights from four months to just one.”

Deploy confident field teams to drive meaningful engagement with HCP Interact

Although data and analytics will help you better understand your audience and which messages and content they’re likely to respond to, launch success still relies on building trust through human interaction.

Field teams can go into HCP meetings armed with everything they need to present a powerful case for your product – but they still have to deliver.

“There’s a tremendous amount of skill involved in those interactions, but one of the challenges pharma companies face is finding the time and best way to help individuals hone their skills in a manner that’s specific to each of their needs,” says Gerard Mortimer, Digital Product Director at Inizio Medical. “To solve this issue, we developed HCP Interact, an immersive AI-powered training simulator that allows field teams to practice interactions at any time.”

It works by allowing reps to converse with a range of realistic HCP personas across different scenarios, which can be tailored depending on training needs. HCP Interact then provides feedback and sends reports to managers to track progress.

Measuring scientific accuracy and conversational skills

“That reporting focuses on two key things,” says Gerard. “One is the scientific objectives – has the field team member conveyed the scientific messaging accurately? And the other part is their conversational skills, so have they demonstrated active listening, asked open questions and probed for more insights?

“HCP Interact uses AI to assess and score the transcript, feeding back to managers who can view and tailor training to close skill gaps.”

Drive performance through continuous optimization with STEM AI and Nazaré

HCP Interact is able to complement our wider framework of platforms, products, and solutions – including the recently launched STEM AI. But whereas the former allows reps to sharpen their skills in a virtual environment, STEM AI analyzes real-life HCP interactions to measure performance, understand how a campaign is resonating, and identify immediate learning opportunities.

Creating a continuous training and performance feedback loop

Together, these tools create a continuous feedback loop, connecting training with insights from real-world interactions.

“By bringing these individual tools together into a closed-loop ecosystem, we can combine capabilities from across Inizio to deliver a compounding benefit for field teams,” David Woods, Vice President and Portfolio Lead, Medical Analytics and Innovation at Inizio Medical, highlighted.

Completing that 4D loop is Nazaré, our specialty learning and capability brand, which offers learning capsules, as Chris Savage explains:

“Each capsule provides a complete dose of development, and includes a toolkit for leaders to deliver training, bite-sized modules on key subjects, live / virtual workshops, and practice packs that enable teams to take what they’ve learned and apply it on the job.”

“Capsules come in a broad range of topics and are specifically designed to help teams drive launch excellence through a complete learning journey.”

Unlock Intelligent Commercialization™ across the product lifecycle

By bringing together human expertise with data, tech, and AI tools, we can help you prepare for launch, drive better engagements and unlock Intelligent Commercialization™ at every stage of the product lifecycle.

To find out more about how Intelligent Commercialization™ can help with your next launch, get in touch.